scispace - formally typeset
D

Dragan Lovic

Researcher at European Society of Cardiology

Publications -  46
Citations -  16251

Dragan Lovic is an academic researcher from European Society of Cardiology. The author has contributed to research in topics: Medicine & Blood pressure. The author has an hindex of 12, co-authored 36 publications receiving 15344 citations.

Papers
More filters
Journal ArticleDOI

Atrial fibrillation and mortality risk in hypertensive patients according to cardiorespiratory fitness

TL;DR: In this article , the authors evaluated the association between cardiorespiratory fitness and mortality risk in hypertensive patients with atrial fibrillation (AF) and established five fitness categories (quintiles) based on age-specific peak metabolic equivalents (METs achieved.
Journal ArticleDOI

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH).

TL;DR: In this paper , the authors present a review of the work of Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici (Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luís Bronze (Portugal), John Chalmers (Australia), Tine De Backer (Belgium), Alejandro de la Sierra (Spain), Kyriakos Dimitriadis (GREEce), Dorota Drozdz (Poland), Béatrice Duly-Bouhanick (France), Brent M. Egan (USA), Claudio Ferri (Italy), Anthony Heagerty (UK), M.
Journal ArticleDOI

Glucomannan and red rice extract reduce blood lipid levels in overweight patients

TL;DR: In this paper , the changes in blood lipid levels, body composition, and blood pressure in healthy middle-aged overweight people with mild hypercholesterolemia following the 45-day intake of a dietary supplement containing both glucomannan and red rice extract were explored.
Journal ArticleDOI

Rationale for the Concept of Impending Hypertension-Mediated Organ Damage.

TL;DR: A consensus on the principles of treating the 'impending hypertensive HMOD' does not exist, making its use inconsistent in emergency departments worldwide.
Journal ArticleDOI

In many patients with hypertensive left ventricular hypertrophy, a beta-blocker is needed because of the prevalent myocardial ischemia.

TL;DR: In this paper , the authors search PubMed, SCOPUS, PubMed, Elsevier, Springer Verlag, and Google Scholar for review articles and guidelines on hypertension from 1/01/2000 until 01/05/2022.